Search research articles
Contact Us
Filters
Showing results (81-90 of 195) with videos related to
Page
of 20
Sort By:
BJU International
|
November 13, 2010
De novo renal cell carcinoma of native and graft kidneys in renal transplant recipients
Igor Tsaur, Nicholas Obermüller, Dietger Jonas, et al.
Cancers
|
April 13, 2024
PD-L1 Expression in High-Risk Non-Muscle-Invasive Bladder Cancer Is Influenced by Intravesical Bacillus Calmette-Guérin (BCG) Therapy
Moritz Maas, Andreas Hilsendecker, Alexandra Pertoll, et al.
Urologic Oncology
|
October 10, 2020
Trends in urologic oncology clinical practice and medical education under COVID-19 pandemic: An international survey of senior clinical and academic urologists
Barak Rosenzweig, Axel Bex, Zohar A Dotan, et al.
Cancers
|
April 24, 2019
Influence of the HDAC Inhibitor Valproic Acid on the Growth and Proliferation of Temsirolimus-Resistant Prostate Cancer Cells In Vitro
Jasmina Makarević, Jochen Rutz, Eva Juengel, et al.
Oncotarget
|
May 4, 2018
Acquired resistance to temsirolimus is associated with integrin α7 driven chemotactic activity of renal cell carcinoma <i>in vitro</i>
Tobias Engl, Jochen Rutz, Sebastian Maxeiner, et al.
BMC Cancer
|
August 27, 2011
Molecular targeting of prostate cancer cells by a triple drug combination down-regulates integrin driven adhesion processes, delays cell cycle progression and interferes with the cdk-cyclin axis
Steffen Wedel, Lukasz Hudak, Jens-Michael Seibel, et al.
Cancer Letters
|
September 20, 2011
The cdk1-cyclin B complex is involved in everolimus triggered resistance in the PC3 prostate cancer cell line
Igor Tsaur, Jasmina Makarević, Lukasz Hudak, et al.
Journal of Clinical Medicine
|
March 10, 2022
High-Normal Preoperative Potassium Level Is Associated with Reduced 30-Day Morbidity and Shorter Hospital Stay after Radical Cystectomy
Hendrik Borgmann, Mohamed M Kamal, Anna Metzger, et al.
The Prostate
|
April 5, 2012
Low dosed interferon alpha augments the anti-tumor potential of histone deacetylase inhibition on prostate cancer cell growth and invasion
Lukasz Hudak, Patrick Tezeeh, Steffen Wedel, et al.
Scandinavian Journal of Urology
|
April 12, 2017
Ruptured angiomyolipoma of the kidney: a rare differential diagnosis of flank pain
Maximilian Peter Brandt, Igor Tsaur, Stefan Vallo, et al.
Page
of 20
Search research articles
Search
Showing results (81-90 of 195) with videos related to
Sort By:
Page
of 20
BJU International
|
November 13, 2010
De novo renal cell carcinoma of native and graft kidneys in renal transplant recipients
Igor Tsaur, Nicholas Obermüller, Dietger Jonas, et al.
Cancers
|
April 13, 2024
PD-L1 Expression in High-Risk Non-Muscle-Invasive Bladder Cancer Is Influenced by Intravesical Bacillus Calmette-Guérin (BCG) Therapy
Moritz Maas, Andreas Hilsendecker, Alexandra Pertoll, et al.
Urologic Oncology
|
October 10, 2020
Trends in urologic oncology clinical practice and medical education under COVID-19 pandemic: An international survey of senior clinical and academic urologists
Barak Rosenzweig, Axel Bex, Zohar A Dotan, et al.
Cancers
|
April 24, 2019
Influence of the HDAC Inhibitor Valproic Acid on the Growth and Proliferation of Temsirolimus-Resistant Prostate Cancer Cells In Vitro
Jasmina Makarević, Jochen Rutz, Eva Juengel, et al.
Oncotarget
|
May 4, 2018
Acquired resistance to temsirolimus is associated with integrin α7 driven chemotactic activity of renal cell carcinoma <i>in vitro</i>
Tobias Engl, Jochen Rutz, Sebastian Maxeiner, et al.
BMC Cancer
|
August 27, 2011
Molecular targeting of prostate cancer cells by a triple drug combination down-regulates integrin driven adhesion processes, delays cell cycle progression and interferes with the cdk-cyclin axis
Steffen Wedel, Lukasz Hudak, Jens-Michael Seibel, et al.
Cancer Letters
|
September 20, 2011
The cdk1-cyclin B complex is involved in everolimus triggered resistance in the PC3 prostate cancer cell line
Igor Tsaur, Jasmina Makarević, Lukasz Hudak, et al.
Journal of Clinical Medicine
|
March 10, 2022
High-Normal Preoperative Potassium Level Is Associated with Reduced 30-Day Morbidity and Shorter Hospital Stay after Radical Cystectomy
Hendrik Borgmann, Mohamed M Kamal, Anna Metzger, et al.
The Prostate
|
April 5, 2012
Low dosed interferon alpha augments the anti-tumor potential of histone deacetylase inhibition on prostate cancer cell growth and invasion
Lukasz Hudak, Patrick Tezeeh, Steffen Wedel, et al.
Scandinavian Journal of Urology
|
April 12, 2017
Ruptured angiomyolipoma of the kidney: a rare differential diagnosis of flank pain
Maximilian Peter Brandt, Igor Tsaur, Stefan Vallo, et al.
Page
of 20